Celularity (CELU) Net Cash Flow (2019 - 2025)

Celularity (CELU) has reported Net Cash Flow for 7 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Cash Flow rose 846.9% year-over-year to $6.1 million in Q4 2025; TTM through Dec 2025 was $5.4 million, a 562.78% increase from a year earlier, with the FY2025 full-year figure at $5.4 million, up 562.78% from the prior year.
• Net Cash Flow was $6.1 million for Q4 2025 at Celularity, up from -$681000.0 in the prior quarter.
• Over five years, Net Cash Flow peaked at $64.5 million in Q3 2021 and troughed at -$35.4 million in Q4 2021.
• A 5-year average of -$2.7 million and a median of -$1.0 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow tumbled 7520.18% in 2021 and surged 846.9% in 2025, its largest moves.
• Over 5 years, Net Cash Flow stood at -$35.4 million in 2021, then climbed by 18.9% to -$28.7 million in 2022, then jumped by 82.79% to -$4.9 million in 2023, then surged by 113.09% to $646000.0 in 2024, then surged by 846.9% to $6.1 million in 2025.
• The last three Net Cash Flow figures came in at $6.1 million (Q4 2025), -$681000.0 (Q3 2025), and $632000.0 (Q2 2025), per Business Quant data.